RxDoctor Payments Data

James Thomas, MD

Emergency Medicine · Cullman, ALNPI 1235175886

Payments from drug & device makers

$419in general payments, 2019–2025

Across 27 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$103
  • Novo Nordisk$76
  • AstraZeneca$76
  • Corium, LLC$71
  • Genentech USA, Inc.$30
  • Kerecis Limited$20
  • plus $44 from 3 others

What the payments were for

  • Food & beverage$419100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$419 in reported general payments places this provider in the 85th percentile of 565 emergency medicine providers in Alabama.

See all emergency medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$96,872
Medicare patients
242
Services billed
2,653

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide52$45,954
MounjaroTirzepatide23$25,411
EliquisApixaban32$19,520
XareltoRivaroxaban30$18,796
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$14,104
JanuviaSitagliptin Phosphate14$7,194
Breo ElliptaFluticasone/Vilanterol18$7,086
Colesevelam Hcl12$5,959
Advair HfaFluticasone Propion/Salmeterol15$5,839
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,308
Albuterol Sulfate HfaAlbuterol Sulfate75$1,855
Atorvastatin Calcium119$1,492
Celecoxib29$1,222
Pilocarpine Hcl11$1,205
Levothyroxine Sodium92$1,188

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$76$45,95452 claims
Lilly USA, LLCMounjaro$103$25,41123 claims
GSKTrelegy Ellipta, Breo Ellipta$15$21,19142 claims
PfizerEliquis$16$19,52032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 565 emergency medicine providers in Alabama.

Other emergency medicine in Cullman

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →